跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIFLEXY 900 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIFLEXY 900
Authorized
STANDARD
BIFLEXY 900
bellco srl
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
41c41d1da6568b1f
Company
bellco srl
Type
Standard
Approval Details
Approval Id
41c41d1da6568b1f
Drug Approval Canada Name
BIFLEXY 900
Product Name
BIFLEXY 900
Status
Cancelled Post Market
Status Date
2022-07-02
Original Market Date
2016-08-08
Din
02428601
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Haemodialysis
Schedule
Ethical
Ahfs
40:34.00*
Atc Original
B05ZA HEMODIALYTICS, CONCENTRATES
Atc Name
b 05 za
Aig Number
0104153026
Company Name
bellco srl
Company Address
Via Camurana 1, Mirandola, Modena, Italy, 41037
Active Ingredients
SODIUM BICARBONATE
900 G / CARTRIDGE
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
41c41d1da6568b1f
Type
Standard
Back to Health Canada Approvals